Consolidated Balance Sheets - USD ($) $ in Millions	Feb. 29, 2024	Feb. 28, 2023
Current
Cash and cash equivalents (note 3)	$ 175	$ 295
Short-term Investments	62	131
Accounts receivable, net of allowance of $6 and $1, respectively (note 4 and note 12)	199	120
Other receivables (note 4)	21	12
Income taxes receivable	4	3
Other current assets (note 4)	47	182
Total current assets	508	743
Restricted cash and cash equivalents (note 3)	25	27
Long-term investments	36	34
Other long-term assets (note 4)	57	8
Operating lease right-of-use assets, net	32	44
Property, plant and equipment, net (note 4)	21	25
Intangible assets, net (note 3 and note 4)	154	203
Goodwill (note 3 and note 4)	562	595
Total assets	1,395	1,679
Current
Accounts payable	17	24
Accrued liabilities (note 4)	117	143
Income taxes payable (note 5)	28	20
Short-term debentures	0	367
Deferred revenue, current (note 12)	194	175
Total current liabilities	356	729
Deferred revenue, non-current	28	40
Operating lease liabilities	38	52
Other long-term liabilities	3	1
Long-term notes (note 6)	194	0
Total liabilities	619	822
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Issued and outstanding - 589,232,539 voting common shares (February 28, 2023 - 582,157,203)	2,948	2,909
Deficit	(2,158)	(2,028)
Accumulated other comprehensive income (loss)	(14)	(24)
Total shareholders' equity	776	857
Total liabilities and shareholders' equity	$ 1,395	$ 1,679